Promentis Pharmaceuticals, Inc. Email Format
Pharmaceutical ManufacturingWisconsin, United States2-10 Employees
Promentis Pharmaceuticals, Inc. is a small privately held biopharmaceutical company based in Milwaukee, Wisconsin, focused on discovering and developing therapies for central nervous system disorders. Its approach targets a mechanism believed to restore glutamatergic neurotransmission and rebalance oxidative stress associated with impaired cortical function across CNS diseases. The lead program centers on SXC-2023, aimed at treating various psychiatric disorders with an initial focus on an indication that affects millions and currently lacks an FDA-approved treatment. The company operates in the pharmaceutical manufacturing industry, concentrating on early-stage discovery and development of CNS therapies. With operations in Milwaukee, it maintains a small team pursuing the advancement of its lead compound to address unmet medical needs.